By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Sage Bionetworks today announced a deal with AstraZeneca aimed at the personalized treatment of cancer patients.

The deal, Sage said, may also lead to the development of new cancer therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.